Home › Metastatische kanker › Californië › Mountain View
Metastatische kanker klinische studies in Mountain View, CA
25 studies voor Metastatische kanker zoeken deelnemers op locaties in en rond Mountain View (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mijl verwijderd
- VA Palo Alto Health Care System, Palo Alto · 5 mijl verwijderd
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RekruterenFase 1/2
- Stanford, Palo Alto · 5 mijl verwijderd
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekruterenFase 2/3
- Stanford Cancer Center, Palo Alto · 5 mijl verwijderd
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruterenFase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mijl verwijderd
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RekruterenFase 1/2
- Stanford Medicine, Palo Alto · 5 mijl verwijderd
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekruterenFase 1
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruterenFase 1
- Stanford University Medical Center, Stanford · 5 mijl verwijderd
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruterenFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mijl verwijderd
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- Stanford Cancer Center, Palo Alto · 5 mijl verwijderd
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
RekruterenFase 2
- Stanford University, Palo Alto · 5 mijl verwijderd
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekruterenFase 3
- Research Site, Palo Alto · 5 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RekruterenFase 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mijl verwijderd
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruterenFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mijl verwijderd
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mijl verwijderd
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RekruterenFase 3
- Stanford University School of Medicine, Palo Alto · 5 mijl verwijderd
A Study of LY4175408 in Participants With Advanced Cancer
RekruterenFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mijl verwijderd
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekruterenFase 1/2
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RekruterenFase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mijl verwijderd
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruterenFase 2/3
- Stanford Cancer Institute, Palo Alto · 5 mijl verwijderd
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RekruterenFase 1
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RekruterenFase 1
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
RekruterenObservatieonderzoek
- VA Palo Alto Healthcare System, Palo Alto · 5 mijl verwijderd
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekruterenFase 1
- Stanford Cancer Institute, Palo Alto · 5 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Stanford · 5 mijl verwijderd
Metastatische kanker studies in andere steden
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Andere studies in Mountain View
- Kanker (alle vormen)40 studies
- Borstkanker26 studies
- Niet-kleincellige longkanker21 studies
- Acute myeloïde leukemie19 studies
- Eierstokkanker19 studies
- Autismespectrumstoornis17 studies
- Longkanker17 studies
- Prostaatkanker15 studies
- Hartfalen15 studies
- Autisme13 studies
- Acute lymfoblastaire leukemie13 studies
- Colorectale kanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.